[Effect of the beta receptor affecting substance Iproveratril on heart rate and arrhythmia].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use*; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D009570:Nitriles; D014665:Vasodilator Agents
Zur Beeinflussbarkeit von Herzfrequenz und Rhythmusstörungen mit der beta-Rezepotor-affinen Substanz Iproveratril.